Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Discrepancy of Interim PET/CT Responses Based on Visual and Quantitative SUV-Based Assessments in the Patients with Diffuse Large B-Cell Lymphoma and Extranodal Involvements

Deok-Hwan Yang, MD PhD, Joon Ho Moon, MD, PhD, Seung-Shin Lee, MD, Jung-Joon Min, MD, Shin-Young Jeong, MD PhD, Yoo-Jin Lee, MD, Sung-Woo Park, MD, Yee Soo Chae, MD, Young Rok Do, Hyeoung-Joon Kim, MD PhD, Je-Jung Lee

Blood (2015) 126 (23): 1446.

https://doi.org/10.1182/blood.V126.23.1446.1446

Published: 2015

Journal Articles

Frontline Autologous Stem Cell Transplantation As Intensive Consolidation in Patients with Peripheral T Cell Lymphomas: Multicenter Phase II Trial in Korea

Jae-Sook Ahn, MD, PhD, Deok-Hwan Yang, MD, PhD, Yee Soo Chae, MD, PhD, Sang Kyun Sohn, MD, PhD, Jae-Yong Kwak, MD, PhD, Ho-Young Yhim, MD, PhD, Se-Ryeon Lee, MD, PhD, Sung-Hoon Jung, MD, Soo-Young Bae, MD, Yeo-Kyeoung Kim, MD, PhD, Hyeoung-Joon Kim, MD, PhD, Je-Jung Lee, MD, PhD

Blood (2011) 118 (21): 4477.

https://doi.org/10.1182/blood.V118.21.4477.4477

Published: 2011

Journal Articles

The Clinical Outcomes of Autologous Stem Cell Transplantation in Peripheral T Cell Lymphoma: from Retrospective Multicenter Study in Korea.

Deok-Hwan Yang, MD, PhD, Won Seog Kim, MD, PhD, Seok Jin Kim, MD, PhD, Sung Hwa Bae, MD, Sung Hyun Kim, MD, PhD, In Ho Kim, MD, PhD, Yeung-Chul Mun, MD, PhD, Ho-Jin Shin, MD, PhD, Yee Soo Chae, MD, PhD, Jae-Yong Kwak, MD, PhD, Hawk Kim, MD, PhD, Min Kyoung Kim, MD, Jin Seok Kim, MD, PhD, Jin Ho Baek, MD, PhD, Cheol Won Suh, MD, PhD, Hee Sook Park16, MD, PhD

Blood (2007) 110 (11): 1892.

https://doi.org/10.1182/blood.V110.11.1892.1892

Published: 2007

Journal Articles

Retrospective Analysis of Post-Remission Modalities in AML Patients with Normal Karyotype.

Yee Soo Chae, MD, Sang Kyun Sohn, MD, PhD, Jong Gwang Kim, MD, PhD, Yoon Young Cho, MD, Joon Ho Moon, MD, Byung Min Ahn, MD, Shi Nae Kim, MD

Blood (2007) 110 (11): 4258.

https://doi.org/10.1182/blood.V110.11.4258.4258

Published: 2007

Journal Articles

Treatment Outcomes for Imatinib Mesylate and Allogeneic Stem Cell Transplantation in Patients with CML Based on RQ-PCR, and the Efficacy of Dose Escalation of Imatinib Mesylate in Patients with Cytogenetic or Hematologic Resistance.

Sang Kyun Sohn, MD, Yoon Young Cho, MD, Byung Min Ahn, MD, Yee Soo Chae, MD, Jong Gwang Kim, MD, Joon Ho Moon, MD

Blood (2006) 108 (11): 4762.

https://doi.org/10.1182/blood.V108.11.4762.4762

Published: 2006

NARROW

Discrepancy of Interim PET/CT Responses Based on Visual and Quantitative SUV-Based Assessments in the Patients with Diffuse Large B-Cell Lymphoma and Extranodal Involvements

Frontline Autologous Stem Cell Transplantation As Intensive Consolidation in Patients with Peripheral T Cell Lymphomas: Multicenter Phase II Trial in Korea

The Clinical Outcomes of Autologous Stem Cell Transplantation in Peripheral T Cell Lymphoma: from Retrospective Multicenter Study in Korea.

Retrospective Analysis of Post-Remission Modalities in AML Patients with Normal Karyotype.

Treatment Outcomes for Imatinib Mesylate and Allogeneic Stem Cell Transplantation in Patients with CML Based on RQ-PCR, and the Efficacy of Dose Escalation of Imatinib Mesylate in Patients with Cytogenetic or Hematologic Resistance.

Email alerts

ASH Publications

American Society of Hematology

Discrepancy of Interim PET/CT Responses Based on Visual and Quantitative SUV-Based Assessments in the Patients with Diffuse Large B-Cell Lymphoma and Extranodal Involvements

Frontline Autologous Stem Cell Transplantation As Intensive Consolidation in Patients with Peripheral T Cell Lymphomas: Multicenter Phase II Trial in Korea

The Clinical Outcomes of Autologous Stem Cell Transplantation in Peripheral T Cell Lymphoma: from Retrospective Multicenter Study in Korea.

Retrospective Analysis of Post-Remission Modalities in AML Patients with Normal Karyotype.

Treatment Outcomes for Imatinib Mesylate and Allogeneic Stem Cell Transplantation in Patients with CML Based on RQ-PCR, and the Efficacy of Dose Escalation of Imatinib Mesylate in Patients with Cytogenetic or Hematologic Resistance.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only